Evidence map›Paper›PMID 26656455›Full record

ArticleNature reviews. Nephrology2016

Transplantation: The role of RAAS blockade in kidney transplantation.

Robert D Toto

Abstract readComment
In one paragraph

Article in Nature reviews. Nephrology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. RAS blockade in chronic kidney disease: Current evidence and future directions.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  2. Kidney disease in non-kidney solid organ transplantation.World journal of transplantation · 2022
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Molecular remodeling of the renin-angiotensin system after kidney transplantation.Journal of the renin-angiotensin-aldosterone system : JRAAS
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Robert D TotoDivision of Nephrology, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, 10526 Ravenscroft Drive, Dallas, Texas 75390, USA.

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
NCATS NIH HHS UL1 TR001105NCATS NIH HHS UL1TR001105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Kidney TransplantationRenin-Angiotensin SystemAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor BlockersHumansAngiotensin-Converting Enzyme InhibitorsAngiotensin II Type 1 Receptor Blockers

Identifiers

PMID26656455
PMCPMC4760842

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.